[Follow-up of the effect of prolactin-lowering substances].
D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy; D001971:Bromocriptine / Q000627:therapeutic use*; D004873:Ergolines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy; D007247:Infertility, Female / Q000188:drug therapy*; D008090:Lisuride / Q000627:therapeutic use; D008598:Menstruation / Q000187:drug effects; D011388:Prolactin / Q000037:antagonists & inhibitors*
D004873:Ergolines; C004278:D-6-methyl-8-ergolin-1-ylacetic acid amide tartrate; D001971:Bromocriptine; D011388:Prolactin; D008090:Lisuride
Die Kontrolle der Wirkung von prolaktinsenkenden Substanzen.